Загрузка...
A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier
The blood-brain barrier (BBB) protects the brain from toxic substances within the peripheral circulation. It maintains brain homeostasis and is a hurdle for drug delivery to the CNS to treat neurodegenerative diseases, including Alzheimer’s disease and brain tumors. The drug efflux transporter P-gly...
Сохранить в:
| Опубликовано в: : | J Clin Invest |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4855938/ https://ncbi.nlm.nih.gov/pubmed/27043281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI76207 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|